Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
[18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine)
DRUG
2 trials
Sponsors
CellSight Technologies, Inc.
Conditions
Covid19
HIV Infections
SARS-CoV Infection
Phase 2
Imaging Immune Activation in HIV by PET-MR
Recruiting
NCT03684655
CellSight Technologies, Inc.
HIV Infections
Start: 2018-09-21
End: 2025-11-01
Target: 30
Updated: 2024-10-24
Imaging Immune Activation in COVID-19
Recruiting
NCT04815096
CellSight Technologies, Inc.
Covid19, SARS-CoV Infection
Start: 2021-04-15
End: 2028-10-01
Target: 80
Updated: 2026-05-08